-
-
-
-
-
-
-
Century Therapeutics, Inc. (IPSC) Reports In-Line Q2 EPS
-
-
-
-
-
-
-
Century Therapeutics, Inc. (IPSC) Tops Q2 EPS by 7c
-
-
-
-
-
-
-
Century Therapeutics, Inc. (IPSC) Misses Q4 EPS by 168c
-
-
-
-
-
-
-
Century Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Updates
-
-
-
-
-
-
-
Century Therapeutics and Bristol Myers Squibb Enter into a Strategic Collaboration to Develop iPSC-derived Allogeneic Cell Therapies
-
-
-
-
-
-
-
Hercules Capital Reports Second Quarter 2021 Financial Results
1,197,440 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

